Monday, December 09, 2024
BioMarin Announces €60 Million Investment and Expansion of Cork Facility
BioMarin Pharmaceutical Inc. announced a €60 million investment in the expansion of its state-of-the-art facility in Shanbally, Co. Cork., with addition of a new, four-story laboratory facility that will enable the company to increase production capacity for currently approved medicines and create room for future growth. The expansion adds to BioMarin’s footprint in Ireland, where the company operates the manufacturing site in Shanbally, as well as a commercial office in Dublin. The company employs
